Block 2 lect 1 Flashcards

1
Q

Why do we conduct research ?

A

To answer the descriptive
[who, what, when, where]

analytical questions
[why, how]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a drug ?

A

-a product intended for use in DX, CURE, TX, PREVENTION of a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the drug discovery process :

A

-new insight into a disease state

-new tech
-testing compounds
-unanticipated effects
-eventually a product arises

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

6 major sources of drug products:

A

-semi synthetic (penicillin)
-recombinant DNA tech
-Plant sources (digoxin)
-animal sources (premarin)
-minerals/earth sources
microbiological sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stage 1: Drug Product Discovery

A

-focuses on target tissues and compounds

-LAB SCREENING (3-6 yrs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stage 2: Pre-clinical Studies

A

-determine TOXICITY/ SAFETY

in vitro and in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In Vivo testing consists of:

A

test drugs ON LIVING ANIMALS : 2 mammals and 2 administrations routes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In Vitro:

A

performed outside of normal environment of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Investigational new drug application:

A

-drug sponsor/developer submits IND application BEFORE starting clinical research.

-request approval to give drug to humans
-FDA has 30 days to review the application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stage 3- PHASE 1, Clinical Trails

A

-healthy volunteers or
-with dx/ condition who failed conventional tx

-no control group
-focused on safety, tolerability, toxicity

-70% move on to phase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

stage 3, Phase II Clinical Trials

A

-ppl w/ disease of interest
-placebo group
-focuses on efficacy
-short term side effects

[ideal and controlled conditions]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

efficacy

A

-power to produce a desired result or effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stage 3, Phase III Clinical Trials

A

-ppl w/ disease if interest
-focuses on efficacy AND effectiveness
-most time consuming phase

(superiority over inferiority)

-drug achieves health result under “real world” conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

effectiveness

A

-producing a result that is wanted and have an intended effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vaccine Efficacy:

A

vaccine will reduce risk of infection by irrespective of transmission setting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

New Drug Application Process:

A

-gets through phase III clinical trials
-all trial are complete
-must demonstrate benefits» risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Stage 3, Phase IV Clinical Trials

A

-long-term data from post marketing surveillance

-MONITOR safety and efficacy
(look into rare side effects)

-pharmacovigilance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical Trial Phase 1

A

-toxicity/ tolerability
-healthy volunteers with disease or failure of tx
-unblinded, uncontrolled
<100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Clinical Trial Phase 2

A

-efficacy and safety
-subjects with target disease
RCT
1-2 yrs
>100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Clinical Trial phase III

A

-efficacy, effectiveness, and safety
-subjects with target disease
RCT
-several years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical Trail phase IV

A

-long term data
-target disease and additional disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is research design?

A

-plan that allows researchers to gather answers to study questions

-provide valid results: Internal vs external

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Internal Validity:

A

degree which results of a study are correct to members od the source pop. (free from bias)

[quality of design]

-STATISTICALLy SIG?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

External validity:

A

results are true to members outside source population (generalize)
[applicability to practice]

CLINICALLY SIG?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The 9 causation considerations:
-temporarily -strength -biological gradient -consistency -specificity -plausibility -coherence -analogy -experiment
26
temporality:
cause must occur before the effect
27
strength
plausibility inc. strength of relationship btw. variables
28
biological gradient
linear relationship btw tx and clinical outcome
29
consistency
cause and effect relationship observed across different settings
30
specificity
A single cause for an effect
31
plausibility
possibility for relationship btw casue and effect
32
coherence
cause and effect consistent w existing knowledge
33
analogy
phenomenon may show causation
34
experiment
-cause can be manipulated, leading to changes in effect
35
Experimental Designs:
researchers CONTROL one variable to see the other variable impact [RCT]
36
Observational Designs:
researcher OBSERVES two variables (case control)
37
Prospective
-data collection after study -determine variable and objective [RCT, prosp. cohort}
38
Retrospective
-evaluates past or existing data -minimal resources -rely in previous data [case control, retrospective cohort]
39
What are the two types of data classification:
-primary: data collected to answer a research question -secondary: using data from previous collection
40
Primary Data collection: [Self reports]
-collects thoughts, perceptions, attitudes, behaviors
41
Primary Data collection: [observational]
-gather info activities, characteristics, comm., interaction Obtrusive: participant aware is present Unobtrusive: unaware, researcher hidden/ in disguise
42
Primary Data collection: [biological measure't ]
-objective markers -clinical lab testing types: biophysical (BP) , biochemical (chemical) , microbiological
43
Measurement error- -systemic error:
-measurement / observation is always off target in same direction [BIASED]
44
Measurement error: -Random error
-due to chance (statistical adjustments)
45
Systematic Error: aka bias
-changing variables that can alter true values. -assessment bias -threat to internal validity
46
Types of Bias: Selection Bias
-error method from researcher where they select subj. for study participation Direct vs. indirect
47
Types of Bias: Information bias
-error occurs due to : wrong info collect from pt, or not the same effort put into both groups -different sources , data from previous records,
48
Types of information bias: recall reporting
-recall: defects in memory -reporting: one group reports more than the other (occurs in personal or sensitive)
49
Types of Bias: Confounding
-error that occurs when outcome of interest is influenced by outside factor -mask assoc. or falsely demonstrate assoc.
50
two ways to reduce systemic error:
-blind-masking -randomization
51
blind masking:
- those involved in research are unaware of participant allocation open label, single blind, double blind, triple blind
52
open label
-no blinding; least objective -all involved are aware
53
single blind
-one of those involved is unaware tx -participant is blinded
54
double blind
-subj. and investigators are unaware of tx allocation -phase 3 trials -
55
triple blind
-MOST OBJ. participants, investigators, and those resp. for monitoring data are blinded
56
randomization:
-all participants have equal chance to be assigned to intervention or control simple, block, stratified, adaptive
57
Randomization: Simple
-single sequence of random assignments easy for larger sizes
58
Randomization: Block
-put subjects to test -equal in size
59
Randomization: stratified
predefined strata based on what researchers find important
60
Randomization: adaptive
-modification of randomization